33. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, et al. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109–1121. 34. Yu D, Thomas-Tikhonenko A (2002) A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a myc retrovirus is sufficient for tumorogenesis. Oncogene 21: 1922–1927. 35. Erkeland S, Valkhof M, Heijmans-Antonissen C, Delwel R, Valk PJM, et al. (2003) The gene encoding transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood 101: 1111–1117. 36. Ting C-N, Olson MC, Barton KP, Leiden JM (1996) Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384: 474–478. 37. Hendricks RW, Nawijn MC, Engel JD, van Doorninck H, Grosveld R, et al. (1999) Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur J Immunol 29: 1912–1918. 38. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, et al. (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nature Genetics 11: 40–44. 39. Chen D, Zhang G (2001) Enforced expression of GATA-3 transcription factor affects cell fate decisions in hematopoiesis. Exp Hematol 29: 971–980. 40. Anderson MK, Hernandez-Hoyos G, Dionne CJ, Arias AM, Chen D, et al. (2002) Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3. Dev Biol 246: 103–121. 41. Cooper AB, Sawai CM, Sincinska E, Powers SE, Sicinski P, et al. (2006) A unique function for cyclin D3 in early B cell development. Nature Immunol 7: 489–497. 42. Peled JU, Yu JJ, Venkatesh J, Bi E, Ding BB, et al. (2010) Requirement for cyclin D3 in germinal center formation and function. Cell Res 20: 631–646. 43. Cato MH, Chintalapati SK, Yau IW, Omori SA, Rickert RC (2011) Cyclin D3 is selectively required for proliferative expansion of germinal center B cells. Mol Cell Biol 31: 127–137. 44. Bain M, Sinclair J (2005) Targeted inhibition of the transcription factor YY1 in an embryonal carcinoma cell line results in retarded cell growth, elevated levels of p53 but no increase in apoptotic cell death. Eur J Cell Biol 84: 543–553. 45. Wang X, Feng Y, Xu L, Chen Y, Zhang Y, et al. (2008) YY1 restrained cell senescence through repressing the transcription of p16. Biochim Biophys Acta 1783: 1876–1883. 46. Meccia E, Bottero L, Felicetti F, Peschle C, Colombo MP, et al. (2003) HOXB7 expression is regualted by the transcription factors NF-Y, YY1, Sp1 and USF-1. Biochim Biophys Acta 1626: 1–9. YY1 Overexpression Negatively Impacts B Cells 47. Wu S, Shi Y, Mulligan P, Gay F, Landry J, et al. (2007) A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nature Struct Biol 14: 1665–1672. 48. DeKoter RP, Singh H (2000) Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288: 1439–1441. 49. Gil J, Bernard D, Peters G (2005) Role of Polycomb Group proteins in stem cell self-renewal and cancer. DNA Cell Biol 24: 117–125. 50. Gil J, Bernard D, Martinez D, Beach D (2004) Polycomb CBX7 has a unifying role in cellular lifespan. Nature Cell Biol 6: 67–72. 51. Valk-Lingbeek ME, Bruggeman SWM, van Lohuizen M (2004) Stem cells and cancer: The polycomb connection. Cell 118: 409–418. 52. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624–629. 53. Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59–74. 54. Alt F, Rosenberg N, Lewis S, Thomas E, Baltimore D (1981) Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: Rearrangement of heavy but not light chain genes. Cell 27: 381–390. 55. Yu D, Allman D, Goldschmidt M, Atchison ML, Monroe JG, et al. (2003) Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood 101: 1950–1955. 56. Collins LS, Dorshkind K (1987) A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol 138: 1082–1087. 57. Hodawadekar S, Yu D, Cozma D, Freedman B, Sunyer O, et al. (2007) B- lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages. Exp Cell Res 313: 331–340. 58. Findley HW, Cooper MD, Kim TH, Alvarado C, Ragab AH (1982) Two new acute lymphblastic leukemia cell lines with early B-cell phenotypes. Blood 60: 1305–1309. 59. Zweidler-McKay PA, He Y, Xu L, Rodriguez CG, Karnell FG, et al. (2005) Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 106: 3898–3906. 60. Fuxa M, Skok J, Souabni A, Salvagiotto G, Roldan E, et al. (2004) Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy- chain gene. Genes Dev 18: 411–422. 61. Wei F, Zaprazna K, Wang J, Atchison ML (2009) PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol Cell Biol 29: 4612–4622. PLoS ONE | www.plosone.org 13 January 2012 | Volume 7 | Issue 1 | e30656